Few data points exist for this record so far. The page fills in as further notices are published.
Supplier
Bristol Myers Squibb Polska Sp. z o.o.,
Warszawa · POL
Track this recordFree account — get alerted when a contract here runs out.
Awards
2
Total awarded
—
2 joint award(s) counted pro rata
Buyers
2
Sectors
1
Group: Bristol-Myers Squibb GmbH & Co. KGaA(inferred)
Reg. NIP: 5262643500
Contracts this supplier holds that are running out
- 11 Jun 2027estimatedProdukt leczniczy - Lisocabtagene MaraleucelInstytut Hematologii i TransfuzjologiiBristol Myers Squibb Polska Sp. z o.o.,, URTICA Sp.zo.o.PLN 7,788,960
- 8 Jul 2027estimatedZakup i dostawa produktu leczniczego Lisocabtagene maraleucelUNIWERSYTECKI SZPITAL KLINICZNY W POZNANIUBristol Myers Squibb Polska Sp. z o.o.,, Urtica Sp. z o.o.PLN 24,040,000
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Zakup i dostawa produktu leczniczego Lisocabtagene maraleucel | UNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU | Bristol Myers Squibb Polska Sp. z o.o.,, Urtica Sp. z o.o. | PLN 24,040,000 | 27 Jul 2026 |
| Produkt leczniczy - Lisocabtagene Maraleucel | Instytut Hematologii i Transfuzjologii | Bristol Myers Squibb Polska Sp. z o.o.,, URTICA Sp.zo.o. | PLN 7,788,960 | 25 Jun 2026 |